Home > Qtrly Results > BAL PHARMA

BAL PHARMA
Quarterly Results Analysis [Dec2024]

BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
Audited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Revenues ₹73 Cr ₹74 Cr ₹74 Cr ₹95 Cr ₹82 Cr ₹93 Cr ₹70 Cr ₹82 Cr
Expenses ₹65 Cr ₹66 Cr ₹68 Cr ₹85 Cr ₹74 Cr ₹85 Cr ₹64 Cr ₹74 Cr
Operating Income ₹8 Cr ₹8 Cr ₹6 Cr ₹10 Cr ₹8 Cr ₹8 Cr ₹6 Cr ₹8 Cr
Other Income ₹1 Cr ₹0 Cr ₹1 Cr ₹2 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹5 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr
Depreciation ₹3 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr ₹2 Cr
Profit Before Tax ₹1 Cr ₹1 Cr ₹1 Cr ₹6 Cr ₹1 Cr ₹2 Cr ₹0 Cr ₹2 Cr
Profit After Tax ₹1 Cr ₹1 Cr ₹0 Cr ₹6 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹2 Cr
EPS ₹0.30 ₹0.65 ₹0.16 ₹3.46 ₹0.56 ₹0.60 ₹0.05 ₹1.02
Industry Peers & Returns1W1M1Y
BAL PHARMA 0.1% 26.9% 2.9%
SUN PHARMACEUTICAL INDUSTRIES 6% 4% 9.9%
DIVIS LABORATORIES 4.7% 0.3% 52.4%
CIPLA 7% 3.7% 7.2%
TORRENT PHARMACEUTICALS 4.1% 6.4% 25%
DR REDDYS LABORATORIES 6.3% 5% -4.7%
MANKIND PHARMA 11.6% 17.3% 8.8%
ZYDUS LIFESCIENCES -1.6% -5.8% -14.5%
LUPIN 0.8% -1.6% 19.3%

BAL PHARMA Quarterly Revenues

Revenues
Q-o-Q

-0.73 %

Y-o-Y

-10.42 %

Quarters Revenues % Change
Dec2024 ₹73 Cr
-0.73
Sep2024 ₹74 Cr
-0.89
Jun2024 ₹74 Cr
-21.42
Mar2024 ₹95 Cr
15.87
Dec2023 ₹82 Cr
-11.76
Sep2023 ₹93 Cr
31.48
Jun2023 ₹70 Cr
-14.63
Mar2023 ₹82 Cr -

BAL PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

0.82 %

Y-o-Y

-0.47 %

Quarters Operating Profit % Change
Dec2024 ₹8 Cr
0.82
Sep2024 ₹8 Cr
19.03
Jun2024 ₹6 Cr
-32.60
Mar2024 ₹10 Cr
23.05
Dec2023 ₹8 Cr
1.26
Sep2023 ₹8 Cr
19.46
Jun2023 ₹6 Cr
-21.07
Mar2023 ₹8 Cr -
Operating Margins
Q-o-Q

1.63 %

Y-o-Y

11.10 %

Quarters Operating Margin% % Change
Dec2024 10.61%
1.63
Sep2024 10.44%
20.14
Jun2024 8.69%
-14.30
Mar2024 10.14%
6.18
Dec2023 9.55%
14.78
Sep2023 8.32%
-9.17
Jun2023 9.16%
-7.47
Mar2023 9.9% -

BAL PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-50.05 %

Y-o-Y

-38.87 %

Quarters Profit After Tax % Change
Dec2024 ₹1 Cr
-50.05
Sep2024 ₹1 Cr
301.16
Jun2024 ₹0 Cr
-95.32
Mar2024 ₹6 Cr
551.59
Dec2023 ₹1 Cr
-12.47
Sep2023 ₹1 Cr
921.05
Jun2023 ₹0 Cr
-94.13
Mar2023 ₹2 Cr -
PAT Margins
Q-o-Q

-49.65 %

Y-o-Y

-31.73 %

Quarters PAT Margin(%) % Change
Dec2024 0.71 %
-49.65
Sep2024 1.41 %
302.86
Jun2024 0.35 %
-94.02
Mar2024 5.85 %
462.50
Dec2023 1.04 %
-0.95
Sep2023 1.05 %
707.69
Jun2023 0.13 %
-93.37
Mar2023 1.96 % -

BAL PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-53.85 %

Y-o-Y

-46.43 %

Quarters EPS % Change
Dec2024 ₹0.3
-53.85
Sep2024 ₹0.65
306.25
Jun2024 ₹0.16
-95.38
Mar2024 ₹3.46
517.86
Dec2023 ₹0.56
-6.67
Sep2023 ₹0.6
1,100.00
Jun2023 ₹0.05
-95.10
Mar2023 ₹1.02 -

You may also like the below Video Courses